Li YM - Search Results

1

Relationship between nonalcoholic fatty liver disease and metabolic syndrome.

Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Chen SH, et al. Among authors: li ym. J Dig Dis. 2011 Apr;12(2):125-30. doi: 10.1111/j.1751-2980.2011.00487.x. J Dig Dis. 2011. PMID: 21401898

2

[An epidemiological survey of alcoholic liver disease in Zhejiang province].

Li YM, Chen WX, Yu CH, Yue M, Liu YS, Xu GY, Ji F, Li SD. Li YM, et al. Among authors: li sd. Zhonghua Gan Zang Bing Za Zhi. 2003 Nov;11(11):647-9. Zhonghua Gan Zang Bing Za Zhi. 2003. PMID: 14636435 Chinese.

3

[Evaluation of treatments for nonalcoholic fatty liver disease].

Li YM. Li YM. Zhonghua Gan Zang Bing Za Zhi. 2005 Feb;13(2):141. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15727708 Chinese. No abstract available.

4

Correlation of polymorphism in the interleukin-1 receptor antagonist gene intron 2 with alcoholic liver disease.

Chen WX, Xu GY, Yu CH, Wang P, Yu M, Xu P, Liu YS, Li YM. Chen WX, et al. Among authors: li ym. Hepatobiliary Pancreat Dis Int. 2005 Feb;4(1):41-5. Hepatobiliary Pancreat Dis Int. 2005. PMID: 15730917

5

Determination of serum carbohydrate-deficient transferrin in the diagnosis of alcoholic liver disease.

Liu YS, Xu GY, Cheng DQ, Li YM. Liu YS, et al. Among authors: li ym. Hepatobiliary Pancreat Dis Int. 2005 May;4(2):265-8. Hepatobiliary Pancreat Dis Int. 2005. PMID: 15908327

6

Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients.

Jin HB, Gu ZY, Yu CH, Li YM. Jin HB, et al. Among authors: li ym. Hepatobiliary Pancreat Dis Int. 2005 Aug;4(3):389-92. Hepatobiliary Pancreat Dis Int. 2005. PMID: 16109522

7

[The role of PPAR alpha in the pathogenesis of fatty liver disease].

Xu L, Li YM. Xu L, et al. Among authors: li ym. Zhonghua Gan Zang Bing Za Zhi. 2005 Sep;13(9):715-7. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 16174475 Review. Chinese. No abstract available.

8

[Evaluation of leptin receptor Lys109Arg polymorphism in patients with non-alcoholic fatty liver disease].

Chen SH, Li YM, Jiang LL, Yu CH. Chen SH, et al. Among authors: li ym. Zhonghua Gan Zang Bing Za Zhi. 2006 Jun;14(6):453-5. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16792872 Chinese.

9

Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.

Xu P, Zhang XG, Li YM, Yu CH, Xu L, Xu GY. Xu P, et al. Among authors: li ym. J Zhejiang Univ Sci B. 2006 Aug;7(8):627-33. doi: 10.1631/jzus.2006.B0627. J Zhejiang Univ Sci B. 2006. PMID: 16845716 Free PMC article.

10

[The association of Val227Ala polymorphism of the peroxisome proliferator activated receptor alpha (PPAR alpha) gene with non-alcoholic fatty liver disease].

Chen SH, Li YM, Yu CH, Jiang LL. Chen SH, et al. Among authors: li ym. Zhonghua Gan Zang Bing Za Zhi. 2007 Jan;15(1):64-5. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17244467 Chinese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,683 results

Search Page

Filters